Hypothermic Machine Perfusion in Liver Transplantation-A Randomised Trial and Beyond
- PMID: 35401040
- PMCID: PMC8986981
- DOI: 10.3389/ti.2022.10257
Hypothermic Machine Perfusion in Liver Transplantation-A Randomised Trial and Beyond
Keywords: DCD; hypothermic perfusion; liver transplantation; machine perfusion; oxygen.
Conflict of interest statement
PF is co-founder and Chief Medical Officer of OrganOx Ltd, a company established to develop machine perfusion technology in Transplantation. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
-
Hypothermic Machine Perfusion in Liver Transplantation - A Randomized Trial.N Engl J Med. 2021 Apr 15;384(15):1391-1401. doi: 10.1056/NEJMoa2031532. Epub 2021 Feb 24. N Engl J Med. 2021. PMID: 33626248 Clinical Trial.
References
-
- Jochmans I, Brat A, Davies L, Hofker HS, van de Leemkolk FEM, Leuvenink HGD, et al. Oxygenated versus Standard Cold Perfusion Preservation in Kidney Transplantation (COMPARE): a Randomised, Double-Blind, Paired, Phase 3 Trial. The Lancet (2020) 396(10263):1653–62. 10.1016/s0140-6736(20)32411-9 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
